Indian secondaries: getting across the line
A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination